药明生物将接管德国制药厂,用于生产新冠疫苗等

2021-04-04 林怡龄 亿欧

27日,外媒报道称,德国伍珀耳塔地区将在年内成为疫苗生产地。中国制药企业药明生物将在几周内接管拜耳在伍珀耳塔地区的生产工厂,拜耳现正在准备移交工作。

27日,外媒报道称,德国伍珀耳塔地区将在年内成为疫苗生产地。中国制药企业药明生物将在几周内接管拜耳在伍珀耳塔地区的生产工厂,拜耳现正在准备移交工作。

据悉,该工厂将用于生产新冠疫苗和其他生物制剂的活性成分,在获得当局批准后,正式的生产或于今年12月开始。而拜耳也将在接下来的几个月时间里对中方员工进行培训。

去年12月,药明生物宣布以1.5亿欧元的价格收购拜耳集团伍珀耳塔地区的生物药原液制造工厂,以持续扩大其全球产能。据了解,此次收购的生物药原液厂配有3条1000升灌流和6条2000升流加生产线。这也是药明生物从拜耳手中收购的第二家制药工厂。

去年年初,WuXi Biologics Germany向拜耳购买其位于德国利华古逊的生物药制剂cGMP灌装制造工厂的设施资产,随后由药明生物接管该厂的运营工作、购买相关设备以及该厂房所附的一项长期租赁合同。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1394381, encodeId=1b12139438197, content=<a href='/topic/show?id=6fa7508342c' target=_blank style='color:#2F92EE;'>#德国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50834, encryptionId=6fa7508342c, topicName=德国)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Mon Apr 05 16:09:41 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1517846, encodeId=e03c151e84667, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68866, encryptionId=44156886664, topicName=生产)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a111112788, createdName=ms1343860338762272, createdTime=Mon Apr 05 16:09:41 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581601, encodeId=1dc015816018e, content=<a href='/topic/show?id=22a08e6050d' target=_blank style='color:#2F92EE;'>#药明生物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87605, encryptionId=22a08e6050d, topicName=药明生物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3e016837754, createdName=ms7421025882867189, createdTime=Mon Apr 05 16:09:41 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029349, encodeId=80bd1029349b1, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sun Apr 04 04:09:41 CST 2021, time=2021-04-04, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1394381, encodeId=1b12139438197, content=<a href='/topic/show?id=6fa7508342c' target=_blank style='color:#2F92EE;'>#德国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50834, encryptionId=6fa7508342c, topicName=德国)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Mon Apr 05 16:09:41 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1517846, encodeId=e03c151e84667, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68866, encryptionId=44156886664, topicName=生产)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a111112788, createdName=ms1343860338762272, createdTime=Mon Apr 05 16:09:41 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581601, encodeId=1dc015816018e, content=<a href='/topic/show?id=22a08e6050d' target=_blank style='color:#2F92EE;'>#药明生物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87605, encryptionId=22a08e6050d, topicName=药明生物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3e016837754, createdName=ms7421025882867189, createdTime=Mon Apr 05 16:09:41 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029349, encodeId=80bd1029349b1, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sun Apr 04 04:09:41 CST 2021, time=2021-04-04, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1394381, encodeId=1b12139438197, content=<a href='/topic/show?id=6fa7508342c' target=_blank style='color:#2F92EE;'>#德国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50834, encryptionId=6fa7508342c, topicName=德国)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Mon Apr 05 16:09:41 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1517846, encodeId=e03c151e84667, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68866, encryptionId=44156886664, topicName=生产)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a111112788, createdName=ms1343860338762272, createdTime=Mon Apr 05 16:09:41 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581601, encodeId=1dc015816018e, content=<a href='/topic/show?id=22a08e6050d' target=_blank style='color:#2F92EE;'>#药明生物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87605, encryptionId=22a08e6050d, topicName=药明生物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3e016837754, createdName=ms7421025882867189, createdTime=Mon Apr 05 16:09:41 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029349, encodeId=80bd1029349b1, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sun Apr 04 04:09:41 CST 2021, time=2021-04-04, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1394381, encodeId=1b12139438197, content=<a href='/topic/show?id=6fa7508342c' target=_blank style='color:#2F92EE;'>#德国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50834, encryptionId=6fa7508342c, topicName=德国)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Mon Apr 05 16:09:41 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1517846, encodeId=e03c151e84667, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68866, encryptionId=44156886664, topicName=生产)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a111112788, createdName=ms1343860338762272, createdTime=Mon Apr 05 16:09:41 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581601, encodeId=1dc015816018e, content=<a href='/topic/show?id=22a08e6050d' target=_blank style='color:#2F92EE;'>#药明生物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87605, encryptionId=22a08e6050d, topicName=药明生物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3e016837754, createdName=ms7421025882867189, createdTime=Mon Apr 05 16:09:41 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029349, encodeId=80bd1029349b1, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sun Apr 04 04:09:41 CST 2021, time=2021-04-04, status=1, ipAttribution=)]
    2021-04-04 公卫新人

    新冠肺炎,疫情何时才能消失

    0

相关资讯

辉瑞新冠疫苗对12至15岁人群有效率为100%

辉瑞和BioNTech联合声明称,辉瑞疫苗可在12至15岁的青少年中具有100%保护效力。

辉瑞对12岁以下儿童展开新冠疫苗临床试验

据NEXSTAR、CNBC等外媒报道,美国辉瑞制药公司(Pfizer)近日宣布,已开始对12岁以下儿童展开新冠疫苗临床试验。截至目前,尚未有在儿童及婴儿中使用的新冠疫苗批准上市。

“选择的烦恼”!新冠疫苗单针、双针怎么选?

当前,海外疫情依然严峻,国内疫情得到有效控制。在接种新冠病毒疫苗的选择上,不少民众遇到了“选择的烦恼”:要不要打疫苗?打哪个品种的疫苗更好?单针和双针如何选择?对此,新华社记者

​希腊一女性接种疫苗30分钟后死亡 尚无证据表明死因与接种疫苗有关

一名65岁的女性当地时间3月30日中午在雅典西郊伊利翁市死亡,此前半小时她刚刚在当地的健康中心接种了新冠疫苗。

港澳将于下周一重启接种复星新冠疫苗复必泰

港府宣布4月5日恢复该款疫苗接种,疫苗包装封口在超低温环境下时出现密封性问题,但不影响疫苗质量。

美国一工厂因员工的“人为失误”致1500万剂新冠疫苗报废

美国马里兰州一家新冠疫苗制造工厂由于员工的“人为失误”,导致约1500万剂美国强生公司的新冠疫苗报废。